193 related articles for article (PubMed ID: 22017412)
21. Effect of norcantharidin on N-acetyltransferase activity in HepG2 cells.
Wu LT; Chung JG; Chen JC; Tsauer W
Am J Chin Med; 2001; 29(1):161-72. PubMed ID: 11321474
[TBL] [Abstract][Full Text] [Related]
22. Facile Chemical Access to Biologically Active Norcantharidin Derivatives from Biomass.
Galkin KI; Kucherov FA; Markov ON; Egorova KS; Posvyatenko AV; Ananikov VP
Molecules; 2017 Dec; 22(12):. PubMed ID: 29231880
[TBL] [Abstract][Full Text] [Related]
23. The effects of cantharidin analogues on xanthine oxidase.
Tsauer W; Lin JG; Lin PY; Hsu FL; Chiang HC
Anticancer Res; 1997; 17(3C):2095-8. PubMed ID: 9216670
[TBL] [Abstract][Full Text] [Related]
24. Norcantharidin: research advances in pharmaceutical activities and derivatives in recent years.
Zhou J; Ren Y; Tan L; Song X; Wang M; Li Y; Cao Z; Guo C
Biomed Pharmacother; 2020 Nov; 131():110755. PubMed ID: 33152920
[TBL] [Abstract][Full Text] [Related]
25. Norcantharidin-induced post-G(2)/M apoptosis is dependent on wild-type p53 gene.
Hong CY; Huang SC; Lin SK; Lee JJ; Chueh LL; Lee CH; Lin JH; Hsiao M
Biochem Biophys Res Commun; 2000 Sep; 276(1):278-85. PubMed ID: 11006118
[TBL] [Abstract][Full Text] [Related]
26. Anticancer activity and mechanisms of norcantharidin-Nd3II on hepatoma.
Yang H; Guo W; Xu B; Li M; Cui J
Anticancer Drugs; 2007 Nov; 18(10):1133-7. PubMed ID: 17893513
[TBL] [Abstract][Full Text] [Related]
27. Norcantharidin suppresses cell growth and migration with enhanced anticancer activity of gefitinib and cisplatin in human non-small cell lung cancer cells.
Lee YC; Lee LM; Yang CH; Lin AM; Huang YC; Hsu CC; Chen MS; Chi CW; Yin PH; Kuo CD; Liao JF; Lee HC
Oncol Rep; 2013 Jan; 29(1):237-43. PubMed ID: 23128522
[TBL] [Abstract][Full Text] [Related]
28. [Studies on anti-tumor agents. I: Synthesis and anti-cancer activity of amino acid derivatives of norcantharidin].
Tian SL; Zhao SW; Zhu AT; Fang Y; Li KQ
Yao Xue Xue Bao; 1993; 28(11):870-5. PubMed ID: 8010005
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic effects of cantharidin analogues without bridging ether oxygen on human hepatocellular carcinoma cells.
Yeh CB; Su CJ; Hwang JM; Chou MC
Eur J Med Chem; 2010 Sep; 45(9):3981-5. PubMed ID: 20691337
[TBL] [Abstract][Full Text] [Related]
30. The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?
McCluskey A; Ackland SP; Gardiner E; Walkom CC; Sakoff JA
Anticancer Drug Des; 2001 Dec; 16(6):291-303. PubMed ID: 12375882
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of a norcantharidin-tethered guanosine: Protein phosphatase-1 inhibitors that change alternative splicing.
Kwiatkowski S; Sviripa VM; Zhang Z; Wendlandt AE; Höbartner C; Watt DS; Stamm S
Bioorg Med Chem Lett; 2016 Feb; 26(3):965-968. PubMed ID: 26725024
[TBL] [Abstract][Full Text] [Related]
32. Overview of Cantharidin and its Analogues.
Wang G; Dong J; Deng L
Curr Med Chem; 2018; 25(17):2034-2044. PubMed ID: 28413963
[TBL] [Abstract][Full Text] [Related]
33. Norcantharidin induces apoptosis of breast cancer cells: involvement of activities of mitogen activated protein kinases and signal transducers and activators of transcription.
Yang PY; Chen MF; Kao YH; Hu DN; Chang FR; Wu YC
Toxicol In Vitro; 2011 Apr; 25(3):699-707. PubMed ID: 21266192
[TBL] [Abstract][Full Text] [Related]
34. Involvement of caspase and MAPK activities in norcantharidin-induced colorectal cancer cell apoptosis.
Yang PY; Chen MF; Tsai CH; Hu DN; Chang FR; Wu YC
Toxicol In Vitro; 2010 Apr; 24(3):766-75. PubMed ID: 20040369
[TBL] [Abstract][Full Text] [Related]
35. The antiplasmodial activity of norcantharidin analogs.
Bajsa J; McCluskey A; Gordon CP; Stewart SG; Hill TA; Sahu R; Duke SO; Tekwani BL
Bioorg Med Chem Lett; 2010 Nov; 20(22):6688-95. PubMed ID: 20888768
[TBL] [Abstract][Full Text] [Related]
36. [Studies on antitumor agents II: synthesis and anticancer activity of dehydrogenated carboncyclic analogs of norcantharidin].
Fang Y; Tian SL; Li KQ; Zhao SW; Wang ZY
Yao Xue Xue Bao; 1993; 28(12):931-5. PubMed ID: 8030418
[TBL] [Abstract][Full Text] [Related]
37. Autophagy Suppression Accelerates Apoptosis Induced by Norcantharidin in Cholangiocarcinoma.
Wang Y; Jiang W; Li C; Xiong X; Guo H; Tian Q; Li X
Pathol Oncol Res; 2020 Jul; 26(3):1697-1707. PubMed ID: 31612378
[TBL] [Abstract][Full Text] [Related]
38. Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin.
Liu Q; Sun H; Li X; Sheng H; Zhu L
Molecules; 2022 Nov; 27(22):. PubMed ID: 36431851
[TBL] [Abstract][Full Text] [Related]
39. [Inhibition of the replication of HIV-1 by norcantharidin in vitro].
Peng ZG; Jiang JD; Wu DZ; Chen HS
Yao Xue Xue Bao; 2010 Feb; 45(2):224-7. PubMed ID: 21351432
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and biological activity evaluation of campthothecin-HAA-Norcantharidin conjugates as antitumor agents in vitro.
Wang XH; Huang M; Zhao CK; Li C; Xu L
Chem Biol Drug Des; 2019 Jun; 93(6):986-992. PubMed ID: 30218487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
